Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With <i>RAS</i> Wild-type, Left-Sided Metastatic Colorectal Cancer
PaperCitations, authors & open-access status
Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With <i>RAS</i> Wild-type, Left-Sided Metastatic Colorectal Cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 265 citations, 2023 year and bronze oa status.
265
Citations
2023
Year
bronze
OA Status